NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its addition to the S&P Dow Jones
Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NMSB.AX - Mesoblast LtdHalf Year 2025 Mesoblast Ltd Earnings PresentationFeb 26, 2025 / 10:00PM
Mesoblast Limited (MESO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
NEW YORK, Feb. 23, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today
MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Co
MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Co
We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at where Mesoblast Limited (NASDAQ:MESO) stands against the other long term ASX...
We recently compiled a list of the 10 Best ASX Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Mesoblast Limited (NASDAQ:MESO) stands against other best ...
The ASX200 has hit yet another all-time high of 8,566 points in morning trade. The record was driven by a strong lead from Wall Street as well as buoyant mining and real estate stocks.